Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reza Moghareabed"'
Autor:
Mohammadbagher Tavakoli, Reza Moghareabed, Hossein Taheri, Mahta Noorbakhsh Dehkordy, Elaheh Nasri, Mohsen Saeb, Simin Hemati
Publikováno v:
Advanced Biomedical Research, Vol 13, Iss 1, Pp 92-92 (2024)
Background: The goal of this study was to assess the impact of deep local hyperthermia on oxygen (O2) saturation and infected volumes of lungs on coronavirus disease 2019 (COVID-19) cancer patients. Materials and Methods: Fifty patients who suffered
Externí odkaz:
https://doaj.org/article/0a650fcbf29e45fa9a35eb3d5a0289bf
Publikováno v:
Advanced Biomedical Research, Vol 12, Iss 1, Pp 220-220 (2023)
Background: Coronavirus disease (COVID-19) pandemic around the world has some adverse effects on the human body, and there is limited data about the impacts of this pandemic disease on embolic brain stroke. Materials and Methods: Fifty-two COVID-19 p
Externí odkaz:
https://doaj.org/article/25e8d5035c8f437fa8912e139898793f
Publikováno v:
International Journal of Cancer Management. 14
Background: The aim of this study was to evaluate the dose distribution, as well as tumor control probability (TCP) and normal tissue complications probability (NTCP) models for females with left-sided breast cancer for 3D-CRT, 6, and 9 fields intens
BackgroundThe aim of this study was to evaluate the dose distribution, and also tumor control probability (TCP) and normal tissue complications probability (NTCP) models of left sided breast cancer females for 3D-CRT, 6 and 9 fields IMRT and hypofrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4578bb0df801c4882f85cc3182ec9e6
https://doi.org/10.21203/rs.3.rs-674507/v1
https://doi.org/10.21203/rs.3.rs-674507/v1
Autor:
Simin Hemati, Reza Moghareabed, Ali Akhavan, Saeideh Tavajoh, Mahnaz Roayaei, Maryam Farghadani, Hamid Emami, Awat Feizi
Publikováno v:
Journal of Global Oncology. 5:83-83
83 Background: Breast carcinoma is the second cause of mortality between female cancers and metastasis is the main contributing factor to the mortality in patients with breast cancer. Optimal management for visceral metastatic breast cancer (MBC) rem